Results 1 to 10 of about 734,803 (234)

Human Papillomavirus Vaccines: An Updated Review [PDF]

open access: yesVaccines, 2020
Human papillomavirus (HPV) vaccines, which were introduced in many countries in the past decade, have shown promising results in decreasing HPV infection and related diseases, such as warts and precancerous lesions. In this review, we present the updated
Liqin Cheng, Yan Wang, Juan Du
doaj   +3 more sources

Human Papillomavirus Vaccines. [PDF]

open access: yesJ Infect Dis, 2021
Abstract Human papillomavirus (HPV) vaccines are among the most effective vaccines available, the first to prevent infection by a mucosatropic sexually transmitted infectious agent and to do so without specific induction of mucosal immunity.
Markowitz LE, Schiller JT.
europepmc   +4 more sources

Papillomavirus vaccines [PDF]

open access: yesFrontiers in Bioscience, 1998
The considerable morbidity and mortality associated with certain human papillomaviruses (HPV) has provided the impetus for HPV vaccine development. The design of such vaccines has evolved from an understanding of the nature of HPV infections and their consequences, together with evaluation of the efficacy of different approaches to vaccination in ...
Duggan-Keen, M   +3 more
semanticscholar   +7 more sources

Human Papillomavirus Vaccines

open access: yesReviews in Medical Virology, 2006
AbstractA wealth of epidemiological and molecular evidence has led to the conclusion that virtually all cases of cervical cancer and its precursor intra‐epithelial lesions are a result of infection with one or other of a subset of genital human papillomaviruses (HPVs) suggesting that prevention of infection by prophylactic vaccination would be an ...
Mia R, Schmiedeskamp, Denise R, Kockler
europepmc   +6 more sources

Human papillomavirus vaccines. [PDF]

open access: yesCMAJ, 2017
Human papillomavirus is the most common sexually transmitted infection. Persistent infection with a high-risk HPV type causes virtually all cases of cervical cancer and has been associated with 90% of anal, 70% of vaginal, 40% of vulvar and 65% of penile cancers,[1][1] as well as up to 70 ...
Ismail SJ, Deeks SL.
europepmc   +4 more sources

Human papillomavirus vaccines: A great leap forward [PDF]

open access: yesCase Reports in Women's Health, 2022
Marie Louise Frevert   +1 more
doaj   +2 more sources

Knowledge and attitudes of mothers toward HPV vaccination: A cross-sectional study in Kazakhstan

open access: yesWomen's Health, 2023
Background: Although recommended for all member states of World Health Organization, there is no national human papillomavirus vaccination program in Kazakhstan.
Aisha Babi   +11 more
doaj   +1 more source

Prices of paediatric vaccines in European vaccination programmes

open access: yesVaccine: X, 2023
Objective: To compare the vaccine prices per vaccinated child under 18 and vaccine funding and procurement systems in the national vaccination programmes (NVPs) in Europe.
Heini Salo   +6 more
doaj   +1 more source

Stress keratin 17 enhances papillomavirus infection-induced disease by downregulating T cell recruitment.

open access: yesPLoS Pathogens, 2020
High-risk human papillomaviruses (HPVs) cause 5% of human cancers. Despite the availability of HPV vaccines, there remains a strong urgency to find ways to treat persistent HPV infections, as current HPV vaccines are not therapeutic for individuals ...
Wei Wang   +9 more
doaj   +1 more source

Novel Antigenic Targets of HPV Therapeutic Vaccines

open access: yesVaccines, 2021
Human papillomavirus (HPV) infection is the cause of the majority of cervical cancers and head and neck cancers worldwide. Although prophylactic vaccines and cervical cancer screening programs have shown efficacy in preventing HPV-associated cervical ...
Ditte Rahbæk Boilesen   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy